Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single‐center phase I/II trial

The prognosis of patients with advanced pancreatic cancer is poor. In the present phase I/II study, we have evaluated the safety and the feasibility of Wilms' tumor 1 (WT1) and/or mucin1 (MUC1) peptide‐pulsed dendritic cell (DC) vaccination in combination with chemotherapy in patients with adva...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Therapeutic apheresis and dialysis 2021-08, Vol.25 (4), p.415-424
Hauptverfasser:	Ogasawara, Masahiro, Miyashita, Mamiko, Yamagishi, Yuka, Ota, Shuichi
Format:	Artikel
Sprache:	eng
Schlagworte:	dendritic cell vaccination gemcitabine MUC1 pancreatic ductal adenocarcinoma S‐1 WT1
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!